Please assess the completion status of the following clinical trial:

Trial Title: The Effect Of Dose Titration And Dose Tapering On The Tolerability Of DVS SR In Women With Vasomotor Symptoms

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 8.0

Eligibility Criteria:
Inclusion Criteria:~* Generally healthy, postmenopausal woman who seeks treatment for hot flushes.~* Meets 1 of the following: At least 12 months of spontaneous amenorrhea; At least 6 months of spontaneous amenorrhea with serum follicle-stimulating hormone (FSH) levels \> 40 mIU/mL; At least 6 weeks postsurgical bilateral oophorectomy (with or without hysterectomy). Hysterectomized without bilateral oophorectomy and with serum FSH levels \>40 mIU/mL.~Exclusion Criteria:~* History of a seizure disorder other than a single childhood febrile seizure.~* History or presence of clinically important hepatic or renal disease or other medical disease.~* Presence or recent history of major depressive disorder, bipolar disorder, psychotic disorder, or generalized anxiety disorder requiring therapy.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- A (Type: ACTIVE_COMPARATOR): None
- B (Type: ACTIVE_COMPARATOR): None
- C (Type: ACTIVE_COMPARATOR): None
- D (Type: ACTIVE_COMPARATOR): None
- E (Type: ACTIVE_COMPARATOR): None
- F (Type: ACTIVE_COMPARATOR): None
- G (Type: ACTIVE_COMPARATOR): None
- H (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).